Thyroid hormone (T 3 ) signaling through the thyroid hormone receptor (TR) regulates hepatoma cell growth and pathophysiology, but the underlying mechanisms are unclear at present. Here, we have shown that the oncomir microRNA-21 (miR-21) is activated by T 3 through a native thyroid hormone response element in the primary miR-21 promoter. Overexpression of miR-21 promoted hepatoma cell migration and invasion, similar to that observed with T 3 stimulation in hepatoma cells. Additionally, anti-miR-21-induced suppression of cell migration was rescued by T 3 . The Rac-controlled regulator of invasion and metastasis, T-cell lymphoma invasion and metastasis 1 (TIAM1) was identified as a miR-21 target additionally downregulated by 
Introduction
The thyroid hormone (T 3 ) is an important regulator of growth, development and differentiation in vertebrates. T 3 binds to thyroid hormone receptors (TR) that belong to the nuclear receptor superfamily. Human TRs are encoded by TRα and TRβ genes located on chromosomes 17 and 3, respectively. The two genes yield several polypeptides via alternative splicing and differential promoter usage. The TRα1, TRβ1 and TRβ2 genes encoding functional products have been well characterized.
Accumulating evidence supports a critical role of TRs in carcinogenesis. For instance, aberrant expression of TR has been associated with human cancers (1) . Earlier studies suggest that partial loss of normal TR function occurs due to reduced expression or complete loss of activity resulting in mutations and/or aberrant expression, which in turn, provides an opportunity for tumor cells to proliferate, invade, and metastasize (2) .
MicroRNAs (miRNA) are small ~22-nucleotide RNA molecules that modulate gene expression via the RNA interference (RNAi) pathway. MiRNAs generally exhibit partial complementarity, and often bind within the 3' untranslated region (3'UTR) of target mRNAs, leading to translational repression and/or degradation (3) . Inappropriate expression of miRNAs is strongly associated with carcinogenesis, since the genomic aberrations observed in cancers directly reflect miRNA expression patterns. Moreover, increasing evidence shows that miRNA gene expression is dysregulated in human cancers (4, 5) . Specific over-or underexpression of miRNA is correlated with particular tumor types (6, 7) . To date, a number of miRNAs that appear to function as tumor suppressors or oncogenes have been identified.
A number of earlier studies have reported that T 3 /TR signaling plays a critical role in hepatoma (8) (9) (10) . In addition, miRNAs play a fundamental role in regulating gene expression in multicellular eukaryotes. Therefore, to clarify the functions of specific transcription factors, miRNAs can be evaluated as potential targets. In hepatoma, miRNA expression is frequently dysregulated, and specific miRNAs have been shown to regulate migration and invasion (11) . It is speculated that miRNAs are critical downstream targets of TRs that participate in hepatoma cell progression. To identify the specific miRNA targets of TR, 270 miRNA expression profiles in HepG2-TRα1 cells were obtained in the presence or absence of T 3 using reverse transcriptase stem-loop quantitative polymerase chain reaction (RT-qPCR) analysis. Consequently, several miRNAs up-or downregulated upon T 3 stimulation were detected. We ultimately focused on miR-21, one of the T 3 -modulated miRNAs that is dysregulated in various cancers. Direct regulation of miR-21 by T 3 was confirmed, and the mechanism underlying the effects of T 3 on hepatoma cell migration further investigated.
Materials and Methods

Reverse transcription-quantitative real-time PCR for miRNA and mRNA
The RT-qPCR method for detection of mature miRNAs and mRNAs was performed as described previously (10, 12) .
Cell culture and transfection
The human hepatoma cell lines, HepG2, Hep3B, SK-Hep1 (obtained from American Type Culture Collection) and J7 (gift from Dr. C. S Yang, National Taiwan University, Taiwan) (13) TRα1 and TRβ1-overexpressing cell lines were cultured, as described previously (14) .
The serum was depleted of T 3 (Td) using an earlier procedure (15) . Cells were cultured at 37°C in a humidified atmosphere of 95% air and 5% CO 2 .
Patients and statistical methods
To determine the associations among TRα1, miR-21 and TIAM1 in hepatoma, total RNAs of tumor and adjacent non-tumor liver tissues from 40 hepatoma patients 
98-0798B).
Stable transfection of Hep3B cells with TIAM1 knockdown
RNA interference against TIAM1 (obtained from Academia Sinica in Taiwan), pLKO.1-shTIAM1, was used to deplete endogenous TIAM1 in Hep3B cells.
Specifically, Hep3B cells were transfected with pLKO.1-shTIAM1 using Turbofect TM (Fermentas, Glen Burnie, MD). Transfected cells were incubated and selected in DMEM supplemented with 10% FBS-containing 0.3 μg/ml puromycin for at least 2 weeks until colonies could be picked. The ChIP assay was performed as described in a previous report (8) . The upstream TRE region of the pri-miR-21 gene was amplified with the forward primer, 5'-AGAGGGCGGGCAGTTTCTT-3', starting at nucleotide -1017, and reverse primer, 5'-AATAAGGAAATGACTTATGC-3', starting at nucleotide -958.
Amplified chromatin immunoprecipitation assay
Immunoblot analysis
Proteins were loaded on a 6% or 10% SDS-polyacrylamide gel for electrophoresis before transfer to a PVDF membrane (PerkinElmer, Boston, MA). The membrane was blotted with antibodies specific for TR protein (C4) (16) , TIAM1 (Calbiochem, Darmstadt, Germany), vimentin, β-catenin, phospho-β-catenin (Santa Cruz, Santa Cruz, CA), c-myc (GeneTex, San Antonio, TX), cyclin D1, c-Jun (Epitomics, Burlingame, CA), β-actin and GAPDH (Chemicon, Bedford, MA) for detection. Blots were incubated with horseradish peroxidase-conjugated secondary antibody, and developed using an ECL detection kit (Millipore Corp., Bedford, MA). Immunoblot assays were performed independently at least three times. The intensities of the immunoreactive bands were quantified using Image Gauge software (Fuji Film, Tokyo, Japan).
3'UTR luciferase reporter assay
Full-length TIAM1 (1950 nt) or MSH2 (272 nt) 3'UTR ( Supplementary Fig. S1 ) was synthesized and cloned into the pMIR-REPORT vector (Applied Biosystems, Foster City, CA) containing the luciferase reporter gene (TIAM1 or MSH2 3'UTR wt).
The putative miR-21 recognition sites in TIAM1 or MSH2 3'UTR were subjected to site-directed mutagenesis (TIAM1 or MSH2 3'UTR mut), and the mutated sequences validated via automated DNA sequencing. The pCDH-CMV-MCS-EF1-copGFP and 
Migration and invasion assay
Cells (5×10 4 /200 μl) in serum-free DMEM were seeded onto the upper chambers of Transwell filter devices and DMEM containing 10% FBS added to the lower chambers, as described previously (14) .
Gelatin zymography
An aliquot of concentrated medium (20 μg) from Hep3B-shNeo and -shTIAM1 cell cultures was loaded onto a 10% non-denaturing polyacrylamide gel containing 0.1% gelatin, as described previously (17) .
Animal model
In Model I, male Sprague Dawley (SD) rats were subjected to thyroidectomy (Tx) at 6 weeks of age according to a previous method, with a view to examining the association between T 3 /TR and miR-21 in vivo (10) . To investigate the correlation 
Statistical analysis
Phi correlation coefficients were computed to determine the correlations among the tumor/non-tumor (T/N) ratios of TRα1, miR-21 and TIAM1. Statistical analysis was performed using SPSS version 15.0 (Chicago, IL). Other statistical analysis of data was performed using Student's t-test. Data were considered statistically significant at P<0.05. Values are presented as means ± SD of at least three independent observations.
Results
Expression profiles of miRNA in HepG2 cells treated with or without T 3
Due to low expression of endogenous TRα1 in various hepatoma cell lines ( Supplementary Fig. S2 ), a HepG2 cell line expressing high levels of TRα1 (HepG2-TRα1) was established to identify the miRNA genes potentially regulated by T 3 .
In total, 14 miRNAs potentially regulated by T 3 were identified. Ten of these miRNAs CAN-12-2218 were upregulated by at least 3-fold and four miRNAs were downregulated by at least 2-fold (Supplementary Table S2 ). Among the 14 miRNA candidates, miR-21 has been shown to be upregulated in various cancers, including hepatoma (7), suggestive of a role as a central oncomir (20) . A pilot study additionally revealed miR-21 upregulation by T 3 in HepG2-TRα1 cells. Interestingly, T 3 /TR signaling may exert both oncogenic (10) and tumor suppressor effects (21, 22) . The findings that miR-21 is increased in hepatoma tissue and potentially upregulated as a target of T 3 in HepG2 cells imply that T 3 functions as an oncogene in this case. 
Validation of T 3 -mediated upregulation of miR-21 in HepG2-TR cells
Characterization of TRE in the miR-21 gene
To determine whether the promoter region of pri-miR-21 contains TRE, we analyzed the region 3000 nucleotides upstream of the gene using Vector NTI software. (Fig. 2C, right) . The native TRE of furin associated with TR and RXR was used as a positive control (Fig. 2C, left) , while additive IgG was employed as a negative control in the ChIP assay. In summary, our analytical results demonstrate that miR-21 is a direct TR target gene containing native TRE.
Prediction of miR-21 targets
The possible effects and mechanisms of action of T 3 /TR-induced miR-21 in hepatoma cells were further analyzed. Specific potential miR-21 target genes negatively regulated by T 3 were selected as candidates for study. In total, 307 genes were predicted as miR-21 targets using TargetScan and invasion. Earlier research showed that miR-21 promotes migration and invasion through a miR-21-PDCD4-AP-1 feedback loop in hepatoma cells (28) . Furthermore, a paradoxical role of TIAM1 in migration of various cancers has been documented (23, 29) . Accordingly, we focused on TIAM1 for further study to validate its role in liver carcinogenesis. The issue of whether TIAM1 is also a direct target of miR-21 in hepatoma cells remains to be established. Two sequences with 7 nucleotides (AUAAGCU) of TIAM1 3'UTR, identified as the seed region of miR-21, were predicted using TargetScan. Full-length TIAM1 3'UTR containing two seed regions located at positions +202/+208 and +1861/+1867 were cloned into a cytomegalovirus (CMV)-driven luciferase reporter plasmid. In the presence of TIAM1 3'UTR, miR-21 suppressed luciferase activity. This suppressive effect was diminished upon mutation of the two miR-21 binding sites in HepG2 cells (Fig. 3A, left) . In addition, knockdown of endogenous miR-21 (anti-miR-21) in the presence of TIAM1 3'UTR induced luciferase activity, which was also decreased upon mutation of the seed region of TIAM1 3'UTR (Fig. 3A, right) . To validate the effects of TIAM1 protein expression in the presence of miR-21 in hepatoma cells, Hep3B cells expressing higher levels of TIAM1 than HepG2 cells were employed for further analysis (Fig. 3B, lanes 1, 2) . We observed a decrease in TIAM1 protein expression in the presence of miR-21 (Fig. 3B, lanes 4 vs. 3 ), and conversely, increased TIAM1 expression upon knockdown of endogenous miR-21 (using anti-miR-21) in Hep3B cells (Fig. 3B, lanes 6 vs. 5 ). Based on these findings, we propose that TIAM1 is a direct miR-21 target in hepatoma cells.
Downregulation of TIAM1 by T 3 /TR in Hep3B cells
Since miR-21 is upregulated by T 3 , we further examined whether TIAM1 3'UTR 
luciferase activity is affected by the thyroid hormone. As shown in Fig. 3C , a significant decrease in TIAM1 3'UTR luciferase activity was observed in HepG2-TRα1 cells in the presence of T 3 , compared with that in the absence of T 3 . Subsequently, Hep3B cells expressing high levels of endogenous TIAM1 were used to overexpress TRα1 (Hep3B-TRα1, Fig. 3D ) for the purpose of validating TIAM1 regulation by T 3 . The dose-dependent upregulation of miR-21 in T 3 -treated Hep3B-TRα1 (Fig. 3E ) was similar to that in HepG2-TR cells (Figs. 1B and C) . T 3 -mediated repression of the TIAM1 protein level was observed in Hep3B-TRα1 cells (Fig. 3F, lanes 1-4) . To verify that the effect of T 3 on TIAM1 is mediated, at least in part, through miR-21, knockdown of endogenous miR-21 (using anti-miR-21) in Hep3B-TRα1 cells was performed.
Notably, suppression of TIAM1 protein in Hep3B-TRα1 cells by T 3 was rescued in cells depleted of endogenous miR-21 (Fig. 3F, lanes 6 vs. 8) . The data presented in Figure 3 suggest that negative regulation of TIAM1 by T 3 occurs through T 3 -mediated upregulation of miR-21 in hepatoma cells. MSH2, a tumor suppressor downregulated by T 3 /TR signaling and miR-21, was additionally examined. As shown in Supplementary   Fig. S6A , the luciferase activity of full-length MSH2 3'UTR (272 nt) containing a seed site (positions +33/+39) was inhibited by miR-21, which was partially restored upon mutation of the seed region. Moreover, MSH2 expression was suppressed in the presence of T 3 or upon overexpression of miR-21 (Figs. S6B and S6C, lane 2), and conversely, increased upon knockdown of miR-21 (anti-miR-21, Fig. S6C, lane 4) .
Correlations among TR, miR-21 and TIAM1 in hepatoma patients
To determine whether TR, miR-21 and TIAM1 expression patterns are correlated in hepatoma, total RNA from paired tumor and adjacent non-tumor liver tissues was 
extracted from a series of 40 consecutive hepatoma patients. The T/N ratios of TRα1, miR-21 and TIAM1, assessed using RT-qPCR, are presented in Supplementary Table   S3 . TRα1 RNA expression was higher in 87.5% (35/40) Our analytical results imply that the correlations among TRα1, miR-21 and TIAM1 expression patterns in hepatoma patients are similar to those observed in hepatoma cells in vitro.
T 3 and miR-21 enhance Hep3B cell migration
Stimulation of T 3 promotes migration in HepG2 cells (14) . Consistent with this finding, an earlier study showed that a miR-21 inhibitor suppresses migration of Huh7 cells (30) . To establish the migration properties of Hep3B cells treated with T 3 or displaying elevated miR-21 expression, the transwell assay was performed. Our data showed that migration of Hep3B-TRα1 cells stimulated with T 3 is enhanced (Fig. 4Aa) .
Similarly, cell migration (Fig. 4Ab) and invasion ( malignant tumor types (31) . It is suggested that the EMT markers, vimentin and β-catenin, play important roles in metastasis of hepatoma (32, 33) . Interestingly, increased expression of these two molecules was observed in not only Hep3B-TRα1 cells treated with T 3 , but also miR-21-overexpressing Hep3B cells (Fig. 4C, lanes 1-5) .
The downstream target proteins of β-catenin, c-myc and cyclin D1, were additionally elevated by T 3 (Fig. 4C) . β-Catenin was significantly upregulated (by 1.8-fold) in miR-21-overexpressing Hep3B cells, compared with the control cell line (Fig. 4C lanes   5 vs. 4) , and significantly downregulated (by 60%) in the miR-21 knockdown cell line (Fig. 4C, lanes 7 vs. 6 ). Moreover, vimentin was downregulated upon knockdown of endogenous miR-21 (Fig. 4C, lanes 7 vs. 6 ). Our results collectively indicate that the effects of miR-21 and T 3 on cell migration and metastasis-associated molecules (such as vimentin and β-catenin) are similar in Hep3B cells.
TIAM1 knockdown in Hep3B cells promotes migration and invasion
To investigate the effects of TIAM1 on cell migration and the underlying signaling (Fig. 5A ). In addition, vimentin expression was increased in Hep3B cells depleted of TIAM1 (Fig. 5A ). K1 and K2 cell lines displayed enhanced Supplementary Fig. S7A ), while TIAM1 and MSH2 levels were decreased. Moreover, c-myc and cyclin D1 were upregulated by T 3 ( Supplementary Fig. S7B ), and β-catenin was significantly downregulated in anti-miR-21-expressing cells (Supplementary Fig. S7C ). Phosphorylated β-catenin protein was upregulated in the anti-miR-21-expressing cell line. Expression levels of c-myc, cyclin D1 and vimentin were significantly decreased ( Supplementary Fig. S7C ).
Our data collectively indicate that miR-21 stimulation by T 3 and subsequent TIAM1 suppression promote cell migration and invasion in hepatoma cells, possibly through upregulation of β-catenin, c-myc, c-jun and vimentin ( Fig. 5 and Supplementary Fig.   S7 ).
Suppression of cell migration induced by miR-21 knockdown is rescued by T 3 in
Hep3B-TRα1 cells
To confirm the finding that T 3 /TR signaling promotes cell migration via T 3 -mediated positive regulation of miR-21, Hep3B-TRα1 cells depleted of miR-21 were examined in the presence or absence of T 3 using the transwell migration assay. As shown in Fig. 6 , cell migration was markedly promoted in the presence of T 3 , compared with that in absence of T 3 (Figs. 6A, I vs. II and 6B). The cell migration effect in the absence of T 3 was significantly suppressed after miR-21 knockdown (Fig. 6A, I and 6B), which was rescued following administration of T 3 (Figs. 6A, III vs. IV and 6B).
Moreover, promotion of cell migration by T 3 was markedly repressed after miR-21 knockdown (Fig. 6A, II vs. IV and 6B ). These results demonstrate that T 3 rescues anti-miR-21-mediated suppression of cell migration. Furthermore, T 3 -induced cell migration is inhibited by anti-miR-21. Based on these findings, we propose that T 3 -mediated positive regulation of miR-21 promotes Hep3B cell migration.
Correlations among TR, miR-21 and TIAM1 in vivo
To investigate whether the effects of miR-21 in vitro can be replicated in vivo, three animal models were designed. Firstly, surgical thyroidectomy (Tx) was performed in two groups of 6-week-old male SD rats to determine the in vivo responses of miR-21 to T 3 treatment. One group (Tx+T 3 ) was injected daily with T 3 for two weeks, the second group (Tx) received no T 3 injections, and the third group included sham-operated controls. Rats were sacrificed at the end of the experiment (four weeks after thyroidectomy), and serum collected for T 3 and TSH determination, as described previously (21) . Quantitative polymerase chain reaction (Q-PCR) analysis disclosed that miR-21 expression in the Tx+T 3 group was 2.8-fold that of the sham group, and conversely, 0.7-fold that of the sham group in the Tx group (Fig. 7A) , indicative of a positive correlation between T 3 /TR and miR-21 in vivo.
Secondly, to determine whether the in vitro metastatic effect of miR-21/T 3 occurs in vivo, SCID mice were injected with J7-TRα1 (a highly metastatic hepatoma cell line).
Animals were subjected to hyperthyroid, euthyroid, and hypothyroid conditions after injection (18, 19) . The hyperthyroid group of SCID mice injected with J7-TRα1 cells displayed higher miR-21 expression (Fig. 7B) euthyroid (control) group (Fig. 7C, panels IX vs. III) . Conversely, the hypothyroid group displayed decreased miR-21 ( Fig. 7B ) and higher TIAM1 expression (Fig. 7C, panels VI vs. III). Tumors are marked with black lines. Figures 7C, panels I , II, IV, V, VII and VIII represent hematoxylin and eosin (H&E) staining, with panels II, V and VIII depicting a higher magnification than I, IV and VII, respectively. Finally, SCID mice with miR-21-depleted SK-Hep1 (anti-miR-21) xenografts developed fewer metastatic foci in lungs, as evident from H&E staining (Fig. 7D, panel III) , with a 98.2% decrease in metastatic index (tumor density per cm 2 ) (Fig. 7E) , compared with SK-Hep1-scrambled xenografts (Figs. 7D, panel I, and 7E). Moreover, a stronger dark-brown color representing TIAM1 protein was observed in the tumor areas of SK-Hep1-anti-miR-21 xenografts (Fig. 7D , panel IV, arrowhead), compared to SK-Hep1-scrambled xenografts (Fig. 7D, panel II) . Analogous results were obtained with both in vivo animal and cell culture models.
Discussion
T 3 /TR signaling promotes cell invasiveness involved in hepatoma progression through direct or indirect upregulation of several genes, including furin (10), methionine adenosyltransferase 1A (MAT1A) (9), plasminogen activator inhibitor-1 (PAI-1) (18), and tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) (19) .
MiRNAs are small RNA molecules processed from endogenous precursor RNA with stem-loop structures that negatively regulate gene expression. To date, several tumor progression-related genes have been identified as specific miRNA targets (34, 35) .
Aberrant miRNA expression has been reported in various tumors, including liver cancer (36, 37) . Data from the current study indicate that both T 3 /TR signaling and miRNAs affect tumor cell progression through TIAM1 suppression and upregulation of β-catenin, vimentin and MMP2 (Supplementary Fig. S8 ). Moreover, the correlations among TRα1, miR-21 and TIAM1 expression patterns in hepatoma patients appear similar to those reported in hepatoma cells.
Previous studies have reported that T 3 stimulation affects the expression of specific miRNAs in mouse hepatocyte cells. T 3 upregulates Gpd2, and Mup1 mRNA may be associated with decreased miR-206 expression in the presence of T 3 (38) . However, the molecular mechanism underlying T 3 -mediated regulation of miRNAs remains unclear at present. To our knowledge, this is the first study to clearly demonstrate that the miR-21 promoter region containing native TRE bound to TR and RXR is directly upregulated by T 3 in hepatoma cells. Both T 3 /TR signaling and miR-21 stimulation promoted hepatoma cell migration. Moreover, T 3 and miR-21 stimulation was associated with suppression of TIAM1 protein expression. Our experiments further confirmed that TIAM1 is a direct target gene of miR-21. Notably, suppression of TIAM1 by T 3 was rescued upon knockdown of endogenous miR-21. Suppression of cell migration with anti-miR-21 was partially restored after administration of T 3 . Conversely, T 3 -enhanced cell migration was inhibited upon endogenous miR-21 knockdown. Overall, our analytical data support the promotion of hepatoma cell migration and invasion through a T 3 /TR-miR-21-TIAM1 pathway (Supplementary Fig. S8 ). In addition, the tumor Values are mean ± SD from three independent experiments, each performed in duplicate. * P<0.05; ** P<0.01. 
